Language Select
Varian Logo

Recent News

January 08, 2018
Varian (NYSE: VAR) today announced it has signed a Memorandum of Understanding (MoU) with Ping An Health Technology Co., Ltd, to explore a strategic partnership for expanding access to cancer care... Read more
January 08, 2018
Varian (NYSE: VAR) today announced its Halcyon™ system has received Taiwan FDA approval, which allows the company to market this new cancer treatment system in Taiwan. This approval further... Read more
January 03, 2018
Varian (NYSE: VAR) today announced that it will webcast a conference call to discuss its transition to the new Accounting Standard Codification 606. No financial information concerning the just... Read more

Recent Blog Posts

Jan 03, 2018 | Spot ON Blog
Proton-Man symbolizes the determination and technology that doctors employ when they utilize proton therapy to fight cancer. Proton-Man's mission is to spread the word about proton therapy and... Read more
Nov 29, 2017 | Spot ON Blog
The potential benefits of proton therapy have yet to be realized. That motivated a group of us to undertake a comprehensive look at the physics and technology powering intensity-modulated proton... Read more
Nov 22, 2017 | Centerline
In 2015, Sarah Cannon, the Cancer Institute of HCA Healthcare, announced a new initiative to create an infrastructure and tools to assess and improve the quality, safety and outcomes across HCA... Read more

Get News Releases by Email
Subscribe Now

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
[email protected]

Investor Relations Contact

Mike Bruff
VP, Investor Relations
650.424.5163
[email protected]